The FE-K-guided Therapy May Lead a Better Outcome in Heart Failure Treated with Tolvaptan

Hiasa Ken-Ichi; Fujino Takeo; Sakamoto Takafumi; Ohtani Kisho; Mukai Yasushi; Higo Taiki; Ide Tomomi

首页> 外文期刊>Journal of cardiac failure >The FE-K-guided Therapy May Lead a Better Outcome in Heart Failure Treated with Tolvaptan

【24h】

The FE-K-guided Therapy May Lead a Better Outcome in Heart Failure Treated with Tolvaptan

机译：FE-K指导的治疗可能会导致接受托伐普坦治疗的心力衰竭更好的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of cardiac failure 》 |2015年第10suppla期| 共1页
作者
Hiasa Ken-Ichi; Fujino Takeo; Sakamoto Takafumi; Ohtani Kisho; Mukai Yasushi; Higo Taiki; Ide Tomomi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. The FE-K-guided Therapy May Lead a Better Outcome in Heart Failure Treated with Tolvaptan [J] . Hiasa Ken-Ichi, Fujino Takeo, Sakamoto Takafumi, Journal of cardiac failure . 2015 ,第10Suppla期

机译：FE-K指导的治疗可能会导致接受托伐普坦治疗的心力衰竭更好的结果
2. Relation of Serum Uric Acid Levels and Outcomes Among Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan Trial) [J] . Vaduganathan Muthiah, Greene Stephen J., Ambrosy Andrew P., The American Journal of Cardiology . 2014 ,第11期

机译：心力衰竭加重射血分数降低的住院患者的血清尿酸水平和结果之间的关系（根据托伐普坦试验对加压素拮抗作用在心衰结果研究中的作用）
3. Diuretic Resistance and Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Trial [J] . Journal of cardiac failure . 2013 ,第8Suppla1期

机译：因心力衰竭加重住院的患者的利尿抵抗性和临床结局：EVEREST（心肺血管加压素拮抗作用在心衰中的功效：托伐普坦的结局研究）试验的启示
4. Long-term Outcome of Cardiac Resynchronization Therapy in Patients with Heart Failure and Ventricular Conduction Delay [C] . B. Sun, A. Wang, Y. Zhu, World Congress on Cardiac Pacing and Electrophysiology . 2003

机译：心力衰竭和心室传导延迟患者心脏重新同步治疗的长期结果
5. Adherence to practice guidelines and heart failure patient outcomes before and after implementation of the HEARTFELT (HEART Failure Effectiveness and Leadership Team) intervention. [D] . Dykes, Patricia C. 2004

机译：在实施HEARTFELT（心力衰竭有效性和领导力团队）干预措施前后，都要遵守实践准则和心力衰竭患者的预后。
6. Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan [O] . Kensuke Fujioka, Sumio Mizuno, Taro Ichise, 2019

机译：托伐普坦治疗心力衰竭患者肾功能对中期结局的影响
7. The FE-K-guided Therapy May Lead a Better Outcome in Heart Failure Treated with Tolvaptan [O] . Ken-ichi Hiasa, Takeo Fujino, Takafumi Sakamoto, 2015

机译：Fe-k引导的疗法可能导致用托尔瓦坦治疗的心力衰竭造成更好的结果

The FE-K-guided Therapy May Lead a Better Outcome in Heart Failure Treated with Tolvaptan

著录项

相似文献

相关主题

期刊订阅